Biomarker-assisted characterisation of non-type 2 disease in young asthmatics

N. Tsolakis (Uppsala, Sweden), A. Malinovschi (Uppsala, Sweden), C. Janson (Uppsala, Sweden), K. Alvin (Uppsala, Sweden)

Source: International Congress 2018 – Biomarkers and lung function in airway disease
Session: Biomarkers and lung function in airway disease
Session type: Poster Discussion
Number: 5061
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Tsolakis (Uppsala, Sweden), A. Malinovschi (Uppsala, Sweden), C. Janson (Uppsala, Sweden), K. Alvin (Uppsala, Sweden). Biomarker-assisted characterisation of non-type 2 disease in young asthmatics. 5061

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Persistent/recurrent wheezing in infants and young children - markers for the evolution to asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 335s
Year: 2002

Risk factors for severe bronchial asthma in young adults with childhood-onset asthma
Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control
Year: 2007


The burden of COPD in young individuals: results from EPISCAN II
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021


How many young adults are at risk of COPD?
Source: Eur Respir J 2002; 20: Suppl. 38, 124s
Year: 2002

Study of the connection between COPD, bronchial asthma and diabetes mellitus types 1 and 2
Source: Annual Congress 2009 - Asthma and comorbid conditions
Year: 2009

Different inflammatory phenotypes in adults and children with acute asthma
Source: Eur Respir J 2011; 38: 567-574
Year: 2011



The prevalence of atopic diseases in children of childhood asthmatic adults
Source: Eur Respir J 2002; 20: Suppl. 38, 336s
Year: 2002

Comorbidities and disease specific health status in young and old COPD patients
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009


Dupilumab efficacy in patients with GINA-defined type 2 asthma: TRAVERSE
Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD
Year: 2021



Special phenotypes of obesity at young patients with bronchial asthma
Source: International Congress 2018 – Variant forms of asthma
Year: 2018



Associations between inflammatory endotypes and phenotypes of obesity at young patients with bronchial asthma
Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities
Year: 2020


Prevalence of atopy and respiratory symptoms in type 1 diabetes mellitus (T1DM) patients
Source: Annual Congress 2005 - Environmental factors, allergy and asthma
Year: 2005


Characterization of severe asthma in children over 6 years
Source: International Congress 2017 – Diagnostic tools in paediatric asthma
Year: 2017


Non-typeable Haemophilus influenzae infection of ciliated epithelium from healthy and chronic obstructive pulmonary disease donors
Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease
Year: 2018




The association of obesity with asthma severity in young adults
Source: Eur Respir J 2002; 20: Suppl. 38, 7s
Year: 2002

Non-respiratory diseases in adults with and without asthma by age at diagnosis
Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research
Year: 2021



Comorbidity between chronic obstructive pulmonary disease and type 2 diabetes in adult twins
Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities
Year: 2012

Prevalence and underdiagnosis of COPD by disease severity in middle-aged and elderly
Source: Eur Respir J 2005; 26: Suppl. 49, 470s
Year: 2005

The prevalence of subtypes of type-2 inflammation in a real-life population of patients with difficult-to-control asthma
Source: International Congress 2019 – Clinical aspects of airway diseases
Year: 2019

The emergence of non-smoking COPD
Source: Annual Congress 2009 - LANCET/ERS symposium: “Evolving dimensions of COPD”
Year: 2009